GLP-1s may lower the risk and severity of metabolic syndrome Those with metabolic syndrome have a higher chance of experiencing health issues like type 2 diabetes, stroke, and coronary heart disease serious conditions that can shorten your life
98 Although located in the sinoatrial node, GLP-1 RAs influence the cardiovascular system through several other mechanisms, including the use of myocardial glucose, improvement of left ventricular function, myocardial ischaemic protection, increased heart rate, vasodilation, anti-atherosclerotic effects, and blood pressure reduction
Most trials demonstrated a low risk of bias in key domains, such as randomization, adherence to intended interventions, outcome measurement, and result reporting
This is more likely if you take GLP-1 medications with other diabetes medications like sulfonylureas or insulin
Already activated